Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

CMOD > Sweatman Drug-Drug interactions > Flashcards

Sweatman Drug-Drug interactions Flashcards

1
Q

How the drug affects the body

A

pharmacodynamics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

how the body acts on the drug

A

pharmacokinetics
(L-ADME)
*lending to means of D-D interactions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

1+ 1= 2

A

additivity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

1+1=3

A

synergism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

change in serum blood level

A

pharmacokinetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

receptor/non-receptor interactions

A

pharmacodynamics

*lending to means of D-D interactions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

many drug-drug interactions are susceptible to control by

A

dose adjustment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

co-admin of cyclosporin with erythromycin has what effect

A

increases cyclosporin levels and decreases its cost

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

are all D-D interaction bad

A

no

some actually beneficial

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

why are elderly, women and very young at increased risk for ADR’s

A

decreased capacity to metabolize and excrete drug, normonal changes, immature metobolic mechs etc

*Pharmacokinetics are different than in adults/ men

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

relationship b/w polypharmacy and incidence

A

greater number of concurrent drugs being taken–> increases likelihood of ADR’s
*greater drug exposure=greater likelihood of drug-drug interactions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

therapeutic window

A

MTC-MEC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

lag period on a dose concentration-time curve indicated

A

rate of uptake/distribution following adminstration for orally administered drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

lag time for IV

A

NONE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

duratio of action

A

time for which the plasma concentration is above the MEC for maximal action upon the recptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

drugs with smaller therapeutic windows are more likely to

A

exhibit adverse effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

if the plasma concetration remains within the therapeutic window when interacting with a concurrent drug…will it be apparent

A

NO–> this is why most D-D interaction go unoticed

only when it goes above MTC (toxic) or below MEC (loss of clinical efficacy–>will drug-drug interactions become notiecd

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

High suspicion of drugs affecting which three categories should be monitored for D-D interactions

A
  1. anticoag (thrombosis or hemorrhage)
  2. Cardiovascular (arrhythmogenic events)
  3. CNS (ability to cross BBB can cause sedative or seizure activity)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Classifications of Chemical (D-D) interactions

A
  1. additive
  2. synergistic
  3. potentiation
  4. antagonism
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

outcome of physical changes that occur in all of the four chemical interactions

A

functional changes
chemical changes
dispositional changes
receptor changes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

women need lower doses bc

A

they tend to not clear the drug as rapidly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

most common CYP’s

A

3A4 and 2D6–> expression varies up to 40 fold for 3A4 and these two cyps have MANY different SNP’s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

atorvastatin MOA regarding CYP

A

Enters cell–>binds to nuclear receptor (PXR) which dimerizes with RXR–> binds DNA00> recruits coactivator which binds to TBP at the TATA box–> activates RNA POl II–> upregulates CYP3A4 transcription–> metabolizes Atorvastatin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

atorvastatin induces

A

its OWN metabolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
A concurrent drug can impact the metabolism of other agents via
semi-selective nuclear effects--> bc the enzyme produced via ligan-NR transcription upregulation can metabolism MANY DIFFERENT DRUGS NOT JUST THE ONE THAT CAUSES THE UPREGULATION *EX--> ATORVASTATIN LEADS TO CYP3A4 UPREG--> WHICH WOULD DECREASE ALL OTHER DRUGS BEING TAKEN THAT ARE SUBSTRATES FOR CYP3A4
26
Semiselective nuclear effects can affect which phases of metabolism
phase I -cyp mediated | AND PHASE II--> GLUCORONOSYLTRANSFERASES
27
WARFARIN-RIFAMPIN INTERACTION
BOTH HANDLED BY CYP3A4: taken together--> rifambin induces CYP and warfarin concentration declines--> PRO-THROMBOTIC STATE no longer sufficiently anticoagulated
28
ORAL CONTRACEPTIVES AND RIFAMPIN
RIFAMPIN INCUCES CYP3A4 AND NOW CONTRACEPTIVE LEVELS ARE LOW--> RESULTING IN PARENTHOOD
29
RIFAMPIN AND CYCLOSPORIN AND TAC
RIFAMPIN INDUCES CYP3A4--> cyclosporin and Tac are substrates--> lower plasma levels of tac and clycosporin via increased Cyp activity--> organ rejection
30
Herbal remedies can cause what problems
1. can affect CYP activity--> indirect drug interactions 2. some are anticoagulant which can have an ADDITIVE EFFECT 3. Some possess CNS activity--> additive or antagonistic effects on CNS
31
three forms of CYP inhibition
reversible (most common)- quasi irreversible irreversible
32
most cyp inhibition is
competitive and reversible
33
most cyp inhibitors contain
Nitrogen-->simultaneously binds prosthetic heme iron and lipophillic region of protein *inhibitor potency determined by lipophillicity and strength of bonds
34
Both reversible and quasi-irreversible inhibition is caused by
formation of reactive metabolites that covalently bind to the active site for ever (irreversible) or apprently/effectively forever (quasi) *require at least 1 cycle of CYP catalytic processes
35
STATINS in too high concentrations can cause
Rhabdomyolysis--> breakdown of muscle tissue muscle pain and acute renal failure *monitor via CPK and aldolase
36
so Erythromycin and Statin doctor should-->
Erythromycin--> CYP3A4 inhibitor--> rhabdomyolysis - ->consider another macrolide such as azithromycin which is not a CYP3A4 inhibitor - ->reduce dose of either - ->monitor for muscle enzymes - ->change statin
37
only statins which are substrates CYP3A4
simvastatin lovastatin atorvastatin
38
ranitidine interaction MOA
affects absorption of other drugs | --> raises stomach pH which would caused increased absoprtion of basic drugs
39
ranitidine increases uptake of...
triazolam--> benzo sedative agent | *increases bioavailabiltiy
40
bile sequesterant agents will bind up and decrease absorption of
propanolol--> a beta blocker | *decreases bioavailability
41
heavily protein bound drugs should not be given with...
other protein bound drugs | *warfarin and valproic acid
42
Conditions leading to toxicity/overdose of heavily protien bound drugs
- -> when protein sites become saturated - ->physiologic/pathologic states causing hypo-albuminemia - -> when protein bound fraction is altered and more free drug enters the plasma
43
agents that bind up a toxin and promote safe renal elimination
chelating agens | --> for toxic agents such as iron, mercury etc
44
what is important about wafarin and chronic NSAID use
DUPLICATION OF OVERALL EFFECT | both produce anti-coag state--> but through different effects--> increased bleeding risk
45
MEASURABLE CHARACTERISTIC OF WARFARIN PLUS NSAIDS
INCREASD INR
46
SSRI'S SHOULD NOT BE GIVEN WITH
other drugs or herbal remedies that increase serotinin levels - -> drugs than inhibit CYP metabolism - ->TRYPTANS--RECEPTOR ANTAGONISTS WHICH MAKE SEROTONINE MORE POTENT * CAN LEAD TO SEROTONIN SYNDROME AND HTN CRISIS WITH NON-SELECTIVE MAOI'S
47
DIFFERENT TARGETS, UNRELATED PATHWAYS | *beneficial
AMOXICILLIN + CLAVULANATE
48
DIFFERENT TARGETS, RELATED PATHWAYS *beneficial synergistic
salmeterol + fluticasone salmeterol--> agonist on beta 2 receptors fluticasone upregulates beta 2 receptors *synergistic T-cell activation and apoptosis induction
49
Upstream-Downstream targets *beneficial synergistic
sulfamethexazole + trimethoprim
50
facilitated action
erythromycin + penicillin | *penicillin weakens cell wall (increases effectiveness of erythromycin) and erythromycin is able to penetrate better
51
indirect ineraction with caffeine
xanax and echinacea
52
indirect effect of signalling cytokine
lisinopril and aspirin--> removed PG's | -->coupling effect is removed and Lisinopril effect not as large
53
penicillin ad plavix both have affects on
platelets
54
Enhanced distribution/localization *potentiation effect
ergotamine and caffeine caffiene increases water solubility of ergoteramine thus increasing its absorption
55
additive equivalent action
niacin (b3) + simvastatin | --> both drugs either decrease secretion or decrease synthesis--> lowering LDL
56
captopril leads to what
retension of potassium--> pro-arrhythmogenic ACE inhbitor
57
Same target different binding site
cisplatin + cyclophosphamide --> compliment each others actions
58
Same target: increases capalities
methotrexate + flourouracil | M binds to F when bound to thymydylate synthase--> increase activity
59
Same target: Pharmacologic antagonism
propanolol + salmterol --> taking propanolon cannot respond to salmeterol bc the B2 adrenergic receptor is blocked by propanolon (non-specific beta blocker)
60
when a previously stable pt. starts a new drug and new symptoms start what is assumed to be responsible
the new drug!

CMOD (19 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions